Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lactate dehydrogenase A-like 6B is a protein-coding enzyme thought to participate in the interconversion of lactate and pyruvate, typically using NAD or NADP as a cofactor[1][3][5][7]. While its exact function is not fully characterized, it is classified as a member of the oxidoreductase family with roles in primary metabolic processes such as glycolysis and carbohydrate metabolism. LDHAL6B is most closely linked to the function of L-lactate dehydrogenases, enzymes important for energy metabolism in many tissues. The gene is located on chromosome 15q22.2[1][5], and its paralog is LDHAL6A[3]. It is expressed in several tissues and localized in the cytoplasm and nucleus[3][5]. There are no direct therapeutic or biomarker applications established for this molecule, and disease associations like Dressler's Syndrome are only tentatively supported in databases[3].\n\nNote: LDHAL6B is a relatively less characterized member of the lactate dehydrogenase family compared to LDHA and LDHB. No specific drugs or clinical applications have been reported as of the latest data, and its detailed biological roles and disease relevance remain under investigation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lactate dehydrogenase A-like 6B (LDHAL6B).